card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

Leveraging RNA-Seq for a robust, accurate measure of HLA calling for endpoints in clinical trials

Presentation from The 2017 Immuno-Oncology Summit In Boston, MA
Home / Insights / Leveraging RNA-Seq for a robust, accurate measure of HLA calling for endpoints in clinical trials

Presented at The Immuno-Oncology Summit in August, 2017, this presentation highlights HLA typing in immunotherapy trials, including advantages and difficulties as well as types of HLA typing. This presentation also provides the benefits of HLAProfiler.

Author:
Victor Weigman, Ph.D., Director, Translational Genomics